Product
MEDI3506
4 clinical trials
5 indications
Indication
AsthmaIndication
Chronic Obstructive Pulmonary DiseaseIndication
Chronic BronchitisIndication
Diabetic NephropathyIndication
Atopic DermatitisClinical trial
A Phase II, Randomised, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of MEDI3506 in Adult Participants With Uncontrolled Moderate-to-severe AsthmaStatus: Completed, Estimated PCD: 2022-12-12
Clinical trial
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of MEDI3506 in Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease and Chronic Bronchitis (FRONTIER 4)Status: Completed, Estimated PCD: 2023-05-30
Clinical trial
A Phase 2b Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of MEDI3506 in Subjects With Diabetic Kidney DiseaseStatus: Completed, Estimated PCD: 2023-05-16
Clinical trial
A Phase 2 Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of MEDI3506 in Adult Subjects With Moderate-to-severe Atopic DermatitisStatus: Completed, Estimated PCD: 2022-07-21